Literature DB >> 10443727

Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate.

J I Epstein1, K Lecksell, H B Carter.   

Abstract

OBJECTIVES: To determine the relationship between the location of positive sites, when more than one sextant site shows prostate cancer in a given patient, and pathologic stage, tumor volume, and margin status if radical prostatectomy is performed.
METHODS: We performed biopsies using a spring-loaded biopsy gun on 343 Stage T1c (nonpalpable) radical prostatectomy specimens from each sextant site.
RESULTS: In 56 cases, carcinoma was identified in two separate sextant sites. In 38 cases, the sites were vertical to each other (ie, left apex, left mid); in 8 cases, the sites were diagonal (ie, left apex, right mid); in 5 cases, the sites were horizontal (ie, left apex, right apex); and in 5 cases, they were not contiguous but were separated by an uninvolved sextant site (ie, left apex, left base). Tumors were more likely to be multifocal in cases with diagonally positive biopsies (P <0.0001) and horizontally positive biopsies (P <0.0001) than in those with vertically positive biopsies. No significant differences were found in organ-confined status and margin positivity among cases with different positive biopsy locations. The dominant tumor nodule was larger (mean 2.76 cc) in cases with noncontiguously positive biopsies than in all other groups combined (mean 1.44 cc) (P = 0.017).
CONCLUSIONS: When more than one sextant site shows cancer, there are differences in terms of whether the tumors sampled are multifocal versus solitary depending on which sites are positive. However, no significant differences were found in predicting pathologic stage and margin positivity.

Entities:  

Mesh:

Year:  1999        PMID: 10443727     DOI: 10.1016/s0090-4295(99)00105-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

1.  Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.

Authors:  Katharina Boehm; Pierre Tennstedt; Burkhard Beyer; Jonas Schiffmann; Ann Beckmann; Uwe Michl; Dirk Beyersdorff; Lars Budäus; Markus Graefen; Pierre I Karakiewicz; Georg Salomon
Journal:  World J Urol       Date:  2015-10-19       Impact factor: 4.226

Review 2.  Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning.

Authors:  Drew Moghanaki; Baris Turkbey; Neha Vapiwala; Behfar Ehdaie; Steven J Frank; Patrick W McLaughlin; Mukesh Harisinghani
Journal:  Semin Radiat Oncol       Date:  2016-08-31       Impact factor: 5.934

Review 3.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

4.  Antimicrobial lubricant reduces rectal bacteria at transrectal prostate biopsy: results from a prospective randomized trial.

Authors:  Georg Salomon; Judith Saul; Sandra Prues; Meike Schneider; Lars Budäus; Derya Tilki; Holger Rohde; Axel Haferkamp; Markus Graefen; Katharina Boehm
Journal:  World J Urol       Date:  2018-02-07       Impact factor: 4.226

5.  Systematic analysis of transrectal prostate biopsies using an ink method and specific histopathologic protocol: a prospective study.

Authors:  David Parada; Nahum Calvo; Karla Peña; Vanesa Morente; Rosana Queralt; Pilar Hernandez; Francesc Riu
Journal:  Prostate Cancer       Date:  2011-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.